Fine Foods & Pharmaceuticals NTM SpA (MIL:FF) LT-Debt-to-Total-Asset : 0.15 (As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Fine Foods & Pharmaceuticals NTM SpA LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Fine Foods & Pharmaceuticals NTM SpA's long-term debt to total assests ratio for the quarter that ended in Dec. 2024 was 0.15.

Fine Foods & Pharmaceuticals NTM SpA's long-term debt to total assets ratio increased from Dec. 2023 (0.05) to Dec. 2024 (0.15). It may suggest that Fine Foods & Pharmaceuticals NTM SpA is progressively becoming more dependent on debt to grow their business.

Fine Foods & Pharmaceuticals NTM SpA LT-Debt-to-Total-Asset Historical Data

The historical data trend for Fine Foods & Pharmaceuticals NTM SpA's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fine Foods & Pharmaceuticals NTM SpA LT-Debt-to-Total-Asset Chart

Fine Foods & Pharmaceuticals NTM SpA Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.08

0.14

0.27

0.05

0.15

Fine Foods & Pharmaceuticals NTM SpA Quarterly Data
	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.05	0.18	0.17	0.16	0.15

Fine Foods & Pharmaceuticals NTM SpA LT-Debt-to-Total-Asset Calculation

Fine Foods & Pharmaceuticals NTM SpA's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (A: Dec. 2024 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2024 )	/	Total Assets (A: Dec. 2024 )
	=	35.835	/	242.591
	=	0.15

Fine Foods & Pharmaceuticals NTM SpA's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (Q: Dec. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2024 )	/	Total Assets (Q: Dec. 2024 )
	=	35.835	/	242.591
	=	0.15

Fine Foods & Pharmaceuticals NTM SpA (MIL:FF) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Fine Foods & Pharmaceuticals NTM SpA LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Fine Foods & Pharmaceuticals NTM SpA's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Fine Foods & Pharmaceuticals NTM SpA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Fine Foods & Pharmaceuticals NTM SpA (MIL:FF) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

9S5:Germany

Address

Via Berlino, 39, Verdellino, Zingonia, Bergamo, ITA, 24040

Website

https://www.finefoods.it

Fine Foods & Pharmaceuticals NTM SpA is engaged in contract development and manufacturing of pharmaceuticals, nutraceuticals, and medical devices in solid oral forms. The company produces pharmaceutical products such as powders and granules, tablets, film tablets, and hard gelatin capsules, packed in sachets, blisters, and pillows.